• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090

Professional Introduction to 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde (CAS No. 428482-55-7)

5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, identified by its Chemical Abstracts Service (CAS) number 428482-55-7, represents a unique structural motif that is highly relevant to the development of novel therapeutic agents. Its molecular framework, characterized by the presence of both bromo and chloro substituents, as well as a benzyl oxy group attached to a benzaldehyde core, makes it a versatile intermediate in synthetic chemistry.

The significance of 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde lies in its potential applications across multiple domains, including drug discovery, agrochemical synthesis, and material science. The bromo and chloro functional groups provide reactive sites for further chemical modifications, enabling the construction of more complex molecules through various coupling reactions, such as Suzuki-Miyaura cross-coupling and Friedel-Crafts alkylation. These reactions are pivotal in the synthesis of biaryl compounds, which are known for their broad spectrum of biological activities.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific biological pathways. The benzaldehyde moiety in 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde serves as an excellent scaffold for designing molecules that interact with biological targets such as enzymes and receptors. For instance, studies have demonstrated the utility of benzaldehyde derivatives in the development of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The presence of halogen atoms enhances the lipophilicity of the compound, making it more permeable to biological membranes and thus improving its pharmacokinetic properties.

The pharmaceutical industry has been exploring novel ways to leverage halogenated aromatic compounds for their therapeutic potential. 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde exemplifies this trend, as it has been investigated for its role in synthesizing molecules with anti-inflammatory and anti-proliferative effects. Research has shown that compounds incorporating bromo and chloro substituents often exhibit enhanced binding affinity to biological targets due to increased electronic density and steric hindrance. This property is particularly valuable in drug design, where precise molecular interactions are essential for therapeutic efficacy.

Moreover, the compound’s structural features make it a valuable building block for constructing heterocyclic derivatives. Heterocycles are widely recognized for their diverse biological activities and are prevalent in many FDA-approved drugs. By incorporating 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde into heterocyclic frameworks, chemists can explore new chemical space and potentially discover novel therapeutic candidates with improved pharmacological profiles.

The synthesis of 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde involves multi-step organic transformations that highlight the compound’s synthetic utility. The process typically begins with the bromination of an appropriate precursor followed by selective chlorination and subsequent formation of the benzyl oxy group. These steps require careful optimization to ensure high yields and purity, which are critical for pharmaceutical applications. Advances in catalytic methods have further streamlined these synthetic routes, making the production of complex derivatives more efficient.

In conclusion, 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde (CAS No. 428482-55-7) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features enable diverse chemical modifications, making it a valuable intermediate for synthesizing novel therapeutic agents. As research continues to uncover new applications for halogenated aromatic compounds, 5-Bromo-2-(4-chlorobenzyl)oxybenzaldehyde is poised to play a crucial role in the next generation of drug discovery efforts.

• 667436-67-1(2-(4-Bromobenzyl)oxy-5-chlorobenzaldehyde)
• 443125-98-2(5-Bromo-2-(3,4-dichlorobenzyl)oxybenzaldehyde)
• 428462-38-8(5-Bromo-2-(2-chlorobenzyl)oxybenzaldehyde)
• 62176-38-9(5-Bromo-2-(3,4-dichlorobenzyl)oxybenzoic Acid)
• 62176-35-6(5-Bromo-2-(3-chlorobenzyl)oxybenzoic Acid)
• 588678-17-5(5-Bromo-2-(3-chlorobenzyl)oxybenzaldehyde)
• 62176-36-7(5-Bromo-2-(4-chlorobenzyl)oxybenzoic Acid)
• 62176-33-4(5-Bromo-2-(2-chlorobenzyl)oxybenzoic Acid)
• 588713-65-9(5-Bromo-2-(2,6-dichlorobenzyl)oxybenzaldehyde)
• 428497-04-5(5-Bromo-2-(2,4-dichlorobenzyl)oxybenzaldehyde)